The FGF receptor-1 tyrosine kinase domain regulates myogenesis but is not sufficient to stimulate proliferation

Journal of Cell Biology

Volumn 142, Issue 1, 1998, Pages 241-250

  Kudla, Arthur J ^c   Jones, Nathan C ^a,b   Rosenthal, R Scott ^a,b   Arthur, Kirstin ^e   Clase, Kari L ^d   Olwin, Bradley B ^a,b  

^a UNIVERSITY OF COLORADO   (United States)

^b WALTHER CANCER INSTITUTE   (United States)

^c PURDUE UNIVERSITY   (United States)

^d PURDUE UNIVERSITY   (United States)

^e PURDUE UNIVERSITY   (United States)

Author keywords

Differentiation; Fibroblast growth factor; Myogenesis; Skeletal muscle; Tyrosine kinase

Indexed keywords

FIBROBLAST GROWTH FACTOR RECEPTOR; PROTEIN TYROSINE KINASE;

ANIMAL CELL; ARTICLE; CELL PROLIFERATION; GROWTH REGULATION; GROWTH STIMULATION; LIGAND BINDING; MOUSE; MUSCLE DEVELOPMENT; NONHUMAN; PRIORITY JOURNAL; SKELETAL MUSCLE;

ANIMALS; BINDING SITES; CELL DIFFERENTIATION; CELL DIVISION; CELL LINE; DNA; HUMANS; MICE; MUSCLE, SKELETAL; PHOSPHORYLATION; PROTEIN-TYROSINE KINASES; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 1; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR BETA; RECEPTORS, FIBROBLAST GROWTH FACTOR; RECEPTORS, PLATELET-DERIVED GROWTH FACTOR; TYROSINE;

EID: 0032514146     PISSN: 00219525     EISSN: None     Source Type: Journal    
DOI: 10.1083/jcb.142.1.241     Document Type: Article

References (36)

1. Baldin, V., A.M. Roman, B.I. Bosc, F. Amalric, and G. Bouche. 1990. Translocation of bFGF to the nucleus is G1 phase cell cycle specific in bovine aortic endothelial cells. EMBO (Eur. Mol. Biol. Organ.) J. 9:1511-1517.
2. Bargmann, C.I., M.C. Hung, and R.A. Weinberg. 1986. Multiple independent activations of the neu oncogene by a point mutation altering the transmembrane domain of p185. Cell. 45:649-57.
3. Bargmann, C.I., and R.A. Weinberg. 1988. Increased tyrosine kinase activity associated with the protein encoded by the activated neu oncogene. Proc. Natl. Acad. Sci. USA. 85:5394-5398.
4. Bouche, G., N. Gas, H. Prats, V. Baldin, J.P. Tauber, J. Teissie, and F. Amalric. 1987. Basic fibroblast growth factor enters the nucleolus and stimulates the transcription of ribosomal genes in ABAE cells undergoing G0-G1 transition. Proc. Natl. Acad. Sci. USA. 84:6770-6774.
5. Burgess, W.H., A.M. Shaheen, M. Ravera, M. Jaye, P.J. Donohuc, and J.A. Winkles. 1990. Possible dissociation of the heparin-binding and mitogenic activities of heparin-binding (acidic fibroblast) growth factor-1 from its receptor-binding activities by site-directed mutagenesis of a single lysine residue. J. Cell Biol. 111:2129-2138.
6. Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156-159.
7. Clegg, C.H., T.A. Linkhart, B.B. Olwin, and S.D. Hauschka. 1987. Growth factor control of skeletal muscle differentiation: commitment to terminal differentiation occurs in G1 phase and is repressed by fibroblast growth factor. J. Cell Biol. 105:949-956.
8. De Moerlooze, L., and C. Dickson. 1997. Skeletal disorders associated with fibroblast growth factor receptor mutations. Curr. Opin. Genet. Dev. 7:378-385.
9. DeHamer, M.K., J.L. Guevara, K. Hannon, B.B. Olwin, and A.L. Calof. 1994. Genesis of olfactory receptor neurons in vitro: regulation of progenitor cell divisions by fibroblast growth factors. Neuron. 13:1083-1097.
10. Glass, D.J., E.D. Apel, S. Shah, D.C. Bowen, T.M. DeChiara, T.N. Stitt, J.R. Sanes, and G.D. Yancopoulos. 1997. Kinase domain of the muscle-specific receptor tyrosine kinase (MuSK) is sufficient for phosphorylation but not clustering of acetylcholine receptors: required role for the MuSK ectodomain? Proc. Natl. Acad. Sci. USA. 94:8848-8853.
11. Gospodarowicz, D., J. Weseman, and J. Moran. 1975. Presence in brain of a mitogenic agent promoting proliferation of myoblasts in low density culture. Nature. 256:216-219.
12. Gossen, M., and H. Bujard. 1992. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc Natl. Acad. Sci. USA. 89:5547-51.
13. Hannon, K., A.J. Kudla, M.J. McAvoy, K.L. Clase, and B.B. Olwin. 1996. Differentially expressed fibroblast growth factors regulate skeletal muscle development through autocrine and paracrine mechanisms. J. Cell Biol. 132:1151-1159.
14. Hart, C.E., R.A. Seifert, R. Ross, and D.F. Bowen-Pope. 1987. Synthesis, phosphorylation, and degradation of multiple forms of the platelet-derived growth factor receptor studied using a monoclonal antibody. J. Biol. Chem. 262:10780-10785.
15. Imamura, T., K. Engleka, X. Zhan, Y. Tokita, R. Forough, D. Roeder, A. Jackson, J.A.M. Maier, T. Hla, and T. Maciag. 1990. Recovery of mitogenic activity of a growth factor mutant with a nuclear translocation sequence. Science. 249:1567-1570.
16. Kudla, A.J., M.L. John, D.F. Bowen-Pope, B. Rainish, and B.B. Olwin. 1995. A requirement for fibroblast growth factor in regulation of skeletal muscle growth and differentiation cannot be replaced by activation of platelet-derived growth factor signaling pathways. Mol. Cell. Biol. 15:3238-3246.
17. Lee, J., T.J. Dull, I. Lax, J. Schlessinger, and A. Ullrich. 1989. HER2 cytoplasmic domain generates normal mitogenic and transforming signals in a chimeric receptor. EMBO (Eur. Mol. Biol. Organ.) J. 8:167-173.
18. Lim, R.W., and S.D. Hauschka. 1984. EGF responsiveness and receptor regulation in normal and differentiation-defective mouse myoblasts. Dev. Biol. 105:48-58.
19. Linkhart, T.A., C.H. Clegg, and S.D. Hauschka. 1980. Control of mouse myoblast commitment to terminal differentiation by mitogens. J. Supramol. Structure. 14:483-498.
20. Linkhart, T.A., C.H. Clegg, and S.D. Hauschka. 1981. Myogenic differentiation in permanent clonal myoblast cell lines: regulation by macromolecular growth factors in the culture medium. Dev. Biol. 86:19-30.
21. Mares, J., L. Claesson Welsh, and M. Welsh. 1992. A chimera between platelet-derived growth factor beta-receptor and fibroblast growth factor receptor-1 stimulates pancreatic beta-cell DNA synthesis in the presence of PDGF-BB. Growth Factors. 6:93-101.
22. Mohammadi, M., I. Dikic, A. Sorokin, W.H. Burgess, M. Jaye, and J. Schlessinger. 1996. Identification of six novel autophosphorylation sites on fibroblast growth factor receptor 1 and elucidation of their importance in receptor activation and signal transduction. Mol. Cell. Biol. 16: 977-989.
23. Olwin, B.B., K. Hannon, and A.J. Kudla. 1994. Are fibroblast growth factors regulators of myogenesis in vivo. Prog. Growth Factor Res. 5:145-158.
24. Olwin, B.B., and S.D. Hauschka. 1986. Identification of the fibroblast growth factor receptor of Swiss 3T3 cells and mouse skeletal muscle myoblasts. Biochemistry. 25:3487-3492.
25. Rando, T.A., and H.M. Blau. 1994. Primary mouse myoblast purification, characterization, and transplantation for cell-mediated gene therapy. J. Cell Biol. 125:1275-1287.
26. Rapraeger, A.C., S. Guimond, A. Krufka, and B.B. Olwin. 1994. Regulation by heparan sulfate in fibroblast growth factor signaling. Methods Enzymol. 245:219-240.
27. Reiland, J., and A.C. Rapraeger. 1993. Heparan sulfate proteoglycan and FGF receptor target basic FGF to different intracellular destinations. J. Cell Sci. 105:1085-1093.
28. Resnitzky, D., M. Gossen, H. Bujard, and S.I. Reed. 1994. Acceleration of the G1/S phase transition by expression of cyclins D1 and E with an inducible system. Mol. Cell. Biol. 14:1669-1679.
29. Riedel, H., T.J. Dull, A.M. Honegger, J. Schlessinger, and A. Ullrich. 1989. Cytoplasmic domains determine signal specificity, cellular routing characteristics and influence ligand binding of epidermal growth factor and insulin receptors. EMBO (Eur. Mol. Biol. Organ.) J. 8:2943-2954.
30. Riedel, H., J. Schlessinger, and A. Ullrich. 1987. A chimeric, ligand-binding v-erbB/EGF receptor retains transforming potential. Science. 236:197-200.
31. Sambrook, J., E.F. Fritsch, and T. Maniatis. 1989. Molecular Cloning: A Laboratory Manual. Second ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York. 16.30-16.40.
32. Takebe, Y., M. Seiki, J.-I. Fujisawa, P. Hoy, K. Yokota, K.-I. Arai, M. Yoshida, and N. Arai. 1988. SRa promoter: an efficient and versatile mammalian cDNA expression system composed of the simian virus 40 early promoter and the R-U5 segment of human T-cell leukemia virus type I long terminal repeat. Mol. Cell. Biol. 8:466-472.
33. Wiedlocha, A., P.Ø. Falnes, I.H. Madshus, K. Sandvig, and S. Olsnes. 1994. Dual mode of signal transduction by externally added acidic fibroblast growth factor. Cell. 76:1039-1051.
34. Wiedlocha, A., P.O. Falnes, A. Rapak, R. Munoz, O. Klingenberg, and S. Olsnes. 1996. Stimulation of proliferation of a human osteosarcoma cell line by exogenous acidic fibroblast growth factor requires both activation of receptor tyrosine kinase and growth factor internalization. Mol. Cell. Biol. 16:270-280.
35. Xu, L., T. Sanchez, and C.-F. Zheng. 1997. In vivo signal transduction pathway reporting systems. Strategies. 10:1-3.
36. Yarden, Y., and A. Ullrich. 1988. Growth factor receptor tyrosine kinases. Annu. Rev. Biochem. 57:443-478.